title: Response to letter regarding article, "amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice".
authors.affiliation: Department of Stroke Medicine, Imperial College London, London, United Kingdom.
authors.forename: Roland
authors.initials: R
authors.lastname: Veltkamp
authors.affiliation: Department of Neurology, University Heidelberg, Heidelberg, Germany.
authors.forename: Shin-Young
authors.initials: SY
authors.lastname: Na
authors.affiliation: Department of Neurology, University Heidelberg, Heidelberg, Germany.
authors.forename: Arthur
authors.initials: A
authors.lastname: Liesz
mesh_terms: D000818:Animals; D001921:Brain / Q000276:immunology*; D018106:CD28 Antigens / Q000819:agonists*; D020244:Infarction, Middle Cerebral Artery / Q000276:immunology*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*
chemical_list: D018106:CD28 Antigens